CF
VERA icon

Corebridge Financial’s Vera Therapeutics VERA Stock Holding History

Corebridge Financial’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-22,202
Closed -$533K – 2694
2025
Q1 		$533K Buy
22,202
+155
+0.7% +$4.98K ﹤0.01% 1556
2024
Q4 		$932K Buy
22,047
+1,210
+6% +$53.6K 0.01% 1357
2024
Q3 		$921K Sell
20,837
-129
-0.6% -$4.89K ﹤0.01% 1395
2024
Q2 		$759K Buy
+20,966
New +$832K ﹤0.01% 1482

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return

Corebridge Financial's VERA Position: Q2 2025 in Review

Corebridge Financial sold out of Vera Therapeutics (VERA) in Q2 2025, closing a stake of 22,202 shares — an estimated $533K sold.

Corebridge Financial first reported a position in VERA in Q2 2024 and held it in 4 quarters. The position peaked at $932K in Q4 2024. 172 funds tracked by Wall St. Rank hold VERA as of Q2 2025.

  • Corebridge Financial reported no remaining Vera Therapeutics position as of Q2 2025 after selling out during the quarter.
  • Corebridge Financial sold 22,202 Vera Therapeutics shares in Q2 2025, an estimated $533K.
  • Corebridge Financial first reported a position in Vera Therapeutics in Q2 2024 and held it in 4 quarters.
  • Corebridge Financial's Vera Therapeutics position peaked at $932K in Q4 2024.
  • 172 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2025.

Based on Corebridge Financial's 13F filing for Q2 2025, filed 12 Aug 2025.